First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.

Name: First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.
Author: Hatashima, Alycia

First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population. — المؤلف: Hatashima, Alycia — Future oncology (London, England) 20220603

المؤلف: Hatashima, Alycia
النشر: Future oncology (London, England) 20220603
الوصف: 2521-2532 p.
الموضوعات: Albumins؛ Antineoplastic Combined Chemotherapy Protocols؛ Deoxycytidine؛ Fluorouracil؛ Humans؛ Irinotecan؛ Leucovorin؛ Oxaliplatin